Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Geriatr Oncol. 2016 Oct 13;8(1):69–75. doi: 10.1016/j.jgo.2016.09.004

Table 4. Biomarkers according to chemotherapy status in breast cancer survivors.

Measures, mean (SD) Chemotherapy (N = 23) No Chemotherapy (N = 28)
Oxidation and inflammation
DNA oxidation in WBC, mean (SD) 5.8 (3.4) 5.4 (3.6) 0.713
RNA oxidation in WBC, mean (SD) 23.1 (23.9) 21.2 (17.7) 0.744
Frailty biomarkers
D-dimers, ug/ml 0.47 (0.29) 0.74 (1.41) 0.384
IGF-1, ng/ml 145.9 (42.1) 137.6 (54.4) 0.552
IGFBP-3, ng/ml 3.05 (0.87) 2.87 (0.86) 0.457
IL-6, pg/ml 2.80 (4.30) 5.96 (9.20) 0.136
TNF alpha, pg/ml 3.78 (1.30) 4.4 (1.80) 0.195
Vitamin D, nM 42.4 (21.9) 55.8 (23.6) 0.041
Albumin, mg/ml 745.0 (663.8) 856.9 (1034.0) 0.658